HOBSCOTCH Phase II: A Pragmatic Study of HOBSCOTCH in New England.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Enrollment
- 106
- Locations
- 4
- Primary Endpoint
- Change in Quality of Life
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this study is to determine the feasibility and efficacy of the home-based cognitive self-management program "HOBSCOTCH" delivered at four New England medical centers. It will test the long-term impact and cost-effectiveness of HOBSCOTCH, and whether it can be delivered from a distance utilizing e-health tools for parts of the program.
Detailed Description
HOBSCOTCH (Home Based Self-management and Cognitive Training Changes lives) is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life. HOBSCOTCH Phase II is a replication study of the original HOBSCOTCH study, designed to translate the findings of HOBSCOTCH into a real world setting. This is a multi-center study, with the HOBSCOTCH intervention being implemented at four epilepsy clinics in New England.
Investigators
Barbara Jobst
Staff Physician, Neurology
Dartmouth-Hitchcock Medical Center
Eligibility Criteria
Inclusion Criteria
- •Age 18-70
- •Confirmed diagnosis of epilepsy, with controlled or uncontrolled seizures
- •Subjective memory complaints
- •No changes in antiepileptic and antidepressant medication regimen for 1 month, however brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable
- •Telephone access
Exclusion Criteria
- •Subjects age 66-70 with a mention of a dementing illness in their medical record
- •Severe mental disability or estimated IQ less than 70
- •Significant visual impairment precluding reading or writing
- •No reliable telephone access
Outcomes
Primary Outcomes
Change in Quality of Life
Time Frame: Baseline and months: 3, 6, 9, 12, 15
We will be using Quality of Life in Epilepsy (QOLIE-31). This validated tool contains 16 multi-item scales which assess health related quality of life, emotional well-being, memory and attention deficits, medication effects, seizure control, psychosocial functioning, and health perception
Change in Healthcare Utilization
Time Frame: Baseline and months: 3, 6, 9, 12, 15
We will be using the Healthcare Utilization in Epilepsy (HCU-E). This validated survey is concordant with billing data. It assesses seizure frequency and whether the subject had received any of the following services because of their epilepsy over the past 3 months: hospital ER services, general practice or family doctor visits, neurologist or epilepsy specialist visits, and overnight hospital inpatient stay.
Secondary Outcomes
- Change in Depression(Baseline and months: 3, 6, 9, 12, 15)
- Change in Cognition(Baseline and months: 3, 6, 9, 12, 15)
- Change in Self-Management Practices(Baseline and months: 3, 6, 9, 12, 15)
- Change in Cognitive Function(Baseline and months: 3, 6, 9, 12, 15)